Tumor Necrosis Factor Receptor 2: Its Contribution to Acute Cellular Rejection and Clear Cell Renal Carcinoma

por Wang, Jun, Al-Lamki, Rafia S.
Publicado 2013

Human Organ Culture: Updating the Approach to Bridge the Gap from In Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology

por Al-Lamki, Rafia S., Bradley, John R., Pober, Jordan S.
Publicado 2017

TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells

por Wang, Jun, Al-Lamki, Rafia S, Zhu, Xinwang, Liu, Hanzhe, Pober, Jordan S, Bradley, John R
Publicado 2014

Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133(+) cells in clear cell renal carcinoma

por Bradley, John R., Wang, Jun, Pacey, Simon, Warren, Anne Y., Pober, Jordan S., Al‐Lamki, Rafia S.
Publicado 2020

ID proteins promote the survival and primed-to-naive transition of human embryonic stem cells through TCF3-mediated transcription

por Jiang, Haibin, Du, Mingxia, Li, Yaning, Zhou, Tengfei, Lei, Jia, Liang, Hongqing, Zhong, Zhen, Al-Lamki, Rafia S., Jiang, Ming, Yang, Jun
Publicado 2022

TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway

por Wang, Jun, Ferreira, Ricardo, Lu, Wanhua, Farrow, Samatha, Downes, Kate, Jermutus, Lutz, Minter, Ralph, Al-Lamki, Rafia S., Pober, Jordan S., Bradley, John R.
Publicado 2018

Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma

por Al-Lamki, Rafia S, Wang, Jun, Yang, Jun, Burrows, Natalie, Maxwell, Patrick H, Eisen, Timothy, Warren, Anne Y, Vanharanta, Sakari, Pacey, Simon, Vandenabeele, Peter, Pober, Jordan S, Bradley, John R
Publicado 2016

The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro

por Al-Lamki, Rafia S., Hudson, Nicholas J., Bradley, John R., Warren, Anne Y., Eisen, Tim, Welsh, Sarah J., Riddick, Antony C. P., O’Mahony, Fiach C., Turnbull, Arran, Powles, Thomas, Reverter, Antonio, Harrison, David J., Stewart, Grant D.
Publicado 2020

TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling

por Hurst, Liam A., Dunmore, Benjamin J., Long, Lu, Crosby, Alexi, Al-Lamki, Rafia, Deighton, John, Southwood, Mark, Yang, Xudong, Nikolic, Marko Z., Herrera, Blanca, Inman, Gareth J., Bradley, John R., Rana, Amer A., Upton, Paul D., Morrell, Nicholas W.
Publicado 2017

Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy

por Williams, Geoffrey S., Mistry, Bina, Guillard, Sandrine, Ulrichsen, Jane Coates, Sandercock, Alan M., Wang, Jun, González-Muñoz, Andrea, Parmentier, Julie, Black, Chelsea, Soden, Jo, Freeth, Jim, Jovanović, Jelena, Leyland, Rebecca, Al-Lamki, Rafia S., Leishman, Andrew J., Rust, Steven J., Stewart, Ross, Jermutus, Lutz, Bradley, John R., Bedian, Vahe, Valge-Archer, Viia, Minter, Ralph, Wilkinson, Robert W.
Publicado 2016

Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19

por Wang, Jun, Kotagiri, Prasanti, Lyons, Paul A., Al-Lamki, Rafia S., Mescia, Federica, Bergamaschi, Laura, Turner, Lorinda, Morgan, Michael D., Calero-Nieto, Fernando J., Bach, Karsten, Mende, Nicole, Wilson, Nicola K., Watts, Emily R., Maxwell, Patrick H., Chinnery, Patrick F., Kingston, Nathalie, Papadia, Sofia, Stirrups, Kathleen E., Walker, Neil, Gupta, Ravindra K., Menon, David K., Allinson, Kieren, Aitken, Sarah J., Toshner, Mark, Weekes, Michael P., Nathan, James A., Walmsley, Sarah R., Ouwehand, Willem H., Kasanicki, Mary, Göttgens, Berthold, Marioni, John C., Smith, Kenneth G.C., Pober, Jordan S., Bradley, John R.
Publicado 2022